Robert A. Winn Excellence in Clinical Trials: Clinical Investigator Leadership Award Grant
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- Applicants must meet the following criteria:Be a current Winn CDA Scholar in Oncology
- Completed an oncology subspeciality training.
- Be employed by an institution that is a current/active member of an NCI National Clinical Trials Network.
- Be able to commit at least 30% of full- time effort in during the award period, as confirmed in an institutional Letter of Support.
Overview
The Robert A. Winn Excellence in Clinical Trials Award, supported by the Bristol Myers Squibb Foundation, is a three-year program aimed at oncology graduates of the Winn CDA program. It focuses on enhancing clinical trials knowledge, leadership skills, and mentorship to foster independent clinical researchers. The initiative, led by the American Society of Clinical Oncology, seeks to train 25 clinical trialists over seven years, providing essential salary support and training-related resources.
NOTE: The Clinical Investigator Leadership Awards (Winn-CILA), supported by the Bristol Myers Squibb Foundation, are three-year career and leadership awards designed for oncology graduates of the Winn CDA program. Please see the Career Development Award (Winn CDA) here.
Robert A. Winn Diversity in Clinical Trials: Clinical Investigator Leadership Award (Winn CILA)
The leadership and training program is led by the American Society of Clinical Oncology and funded by the Bristol Myers Squibb Foundation and includes collaboration with the members of the National Cancer Institute’s National Clinical Trials Network (NCTN). The program launched in early 2024 and has a goal of training a total of 25 clinical trialists over a seven-year period. The program will provide salary support for the participants during their award term, support for the NCTN cooperative groups, and other training-related costs.
Eligibility
Applicants must meet the following criteria:Be a current Winn CDA Scholar in Oncology
Completed an oncology subspeciality training.
Be employed by an institution that is a current/active member of an NCI National Clinical Trials Network.
Be able to commit at least 30% of full- time effort in during the award period, as confirmed in an institutional Letter of Support.
What Bristol-Myers Squibb Foundation Inc actually gave
Source: IRS Form 990-PF, 2024
- Grants in 2024
- 144
- Total given
- $67.69M
- Median grant
- $134K
- Range
- $250–$15.18M
- By dollars: New Jersey 100%. Top recipient cities: Princeton, NJ.
- 30% of recipients were new grantees, not repeat recipients.
Example grants
Medical College of Virginia · Princeton, NJ
$15.18M
Charities Aid Foundation of America · Princeton, NJ
Employee giving program
$8.05M
Texas Childrens Hospital · Princeton, NJ
$7M
University of Kentucky Research · Princeton, NJ
$1.54M
Conquer Cancer Foundation · Princeton, NJ
$1.46M
Focus Areas & Funding Uses
Fields of Work
- Science research
- Health disparities
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
CTNNB1 Research Grant Program
CTNNB1 Connect and Cure Inc
Amount
Varies
Deadline
Rolling
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
January 7, 2028
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
National Institutes of Health
Amount
Varies
Deadline
January 7, 2028
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
National Institutes of Health
Amount
Varies
Deadline
January 7, 2028
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
May 8, 2028
Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $300K
Deadline
November 16, 2028
Ready to apply for Robert A. Winn Excellence in Clinical Trials: Clinical Investigator Leadership Award Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Robert A. Winn Excellence in Clinical Trials: Clinical Investigator Leadership Award Grant. Now let's win it.